Cargando…
Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus
Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, known as statins, have revolutionized the treatment of hypercholesterolemia and coronary artery disease prevention. However, there are considerable issues regarding statin safety and further development of residual risk control...
Autores principales: | Kawai, Yasuyuki, Sato-Ishida, Ryoko, Motoyama, Atsushi, Kajinami, Kouji |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100224/ https://www.ncbi.nlm.nih.gov/pubmed/21625418 http://dx.doi.org/10.2147/DDDT.S13492 |
Ejemplares similares
-
Pitavastatin: evidence for its place in treatment of hypercholesterolemia
por: Alagona, Peter
Publicado: (2010) -
Place of intravitreal dexamethasone implant in the treatment armamentarium of diabetic macular edema
por: Karti, Omer, et al.
Publicado: (2021) -
Statins in cardiometabolic disease: what makes pitavastatin different?
por: Ginsberg, Henry
Publicado: (2013) -
Current perspectives on the use of statins in the treatment of dyslipidaemic patients: focus on pitavastatin
por: Tokgözoglu, Lale, et al.
Publicado: (2020) -
Neurosteroids: A Newer And Promising Therapeutic Modality In Psychiatric Armamentarium.
por: K. Mishra, Kshirod, et al.
Publicado: (2022)